Cu chelators such as tetrathiomolybdate (TTM) and Cu 4 (2,4-di-tert-butyl-6-(1H-imidazo- [1, 10] phenanthrolin-2-yl)phenol) 4 ]10 CH 3 CN, a bioinorganic complex 2, have been proposed as potential cancer drugs due to their ability to inhibit Cu-dependent signaling pathways (138)
First isolated from human plasma albumin by Loren Pickart in 1973, GHK-Cu has been studied for its roles in wound healing, tissue remodeling, anti-inflammatory effects, and gene expression modulation
Leg transformation is significant but often underappreciated
Do not reduce frequency until you have established steady-state blood levels and confirmed the medication is working
Incidence of end-stage renal disease following bariatric surgery in the Swedish Obese Subjects Study
The difference between labeled use and intended use raises further safety concerns as these substances do not have to undergo quality control or safety monitoring, unlike FDA-approved substances